Literature DB >> 21921620

Models of preventable disease: contrast-induced nephropathy and cardiac surgery-associated acute kidney injury.

Andrew Shaw1.   

Abstract

In order to prevent a disease, its temporal nature (or at least when it starts) needs to be clearly defined. In acute kidney injury (AKI), this is usually not possible because the current diagnostic criteria are retrospective. Contrast-induced nephropathy (CIN) and cardiac surgery-associated acute kidney injury (CSA-AKI) are both thought of as potentially preventable acute renal lesions because the timing of the insult is known precisely. While this is true, knowledge of the exact biological processes that give rise to each condition is lacking, although there are several common themes - notably ischemia - that pervade the literature describing these diseases. Despite this, progress in prevention has been slow, and to date there are no therapies indicated for preventing either CIN or CSA-AKI. The best we can currently do is to recommend aggressive parenteral hydration, avoid compounds we know are nephrotoxic, and avoid unnecessary hypoxia and hypotension. While there is still clearly a long way to go before either of these acute kidney conditions can be described as preventable, the use of major adverse kidney events - death, dialysis and incident or progressive chronic kidney disease at 90 days - as a composite endpoint in clinical trials of putative prevention agents would represent a significant step forwards.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921620     DOI: 10.1159/000329387

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  12 in total

1.  Association between AKI and long-term renal and cardiovascular outcomes in United States veterans.

Authors:  Lakhmir S Chawla; Richard L Amdur; Andrew D Shaw; Charles Faselis; Carlos E Palant; Paul L Kimmel
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

Review 2.  Bridging translation for acute kidney injury with better preclinical modeling of human disease.

Authors:  Nataliya I Skrypnyk; Leah J Siskind; Sarah Faubel; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-09

3.  Early β-blockers administration might be associated with a reduced risk of contrast-induced acute kidney injury in patients with acute myocardial infarction.

Authors:  Jin Liu; Guoli Sun; Yibo He; Feier Song; Shiqun Chen; Zhaodong Guo; Bowen Liu; Li Lei; Lihao He; Jiyan Chen; Ning Tan; Yong Liu
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

4.  Predicting Major Adverse Kidney Events among Critically Ill Adults Using the Electronic Health Record.

Authors:  Andrew C McKown; Li Wang; Jonathan P Wanderer; Jesse Ehrenfeld; Todd W Rice; Gordon R Bernard; Matthew W Semler
Journal:  J Med Syst       Date:  2017-08-31       Impact factor: 4.460

5.  Balanced Crystalloids versus Saline in Critically Ill Adults.

Authors:  Matthew W Semler; Wesley H Self; Todd W Rice
Journal:  N Engl J Med       Date:  2018-05-17       Impact factor: 91.245

6.  Balanced Crystalloids versus Saline in Critically Ill Adults.

Authors:  Matthew W Semler; Wesley H Self; Jonathan P Wanderer; Jesse M Ehrenfeld; Li Wang; Daniel W Byrne; Joanna L Stollings; Avinash B Kumar; Christopher G Hughes; Antonio Hernandez; Oscar D Guillamondegui; Addison K May; Liza Weavind; Jonathan D Casey; Edward D Siew; Andrew D Shaw; Gordon R Bernard; Todd W Rice
Journal:  N Engl J Med       Date:  2018-02-27       Impact factor: 91.245

7.  Contrast induced acute kidney injury and the role of beta-blockers in its prevention.

Authors:  Umberto Barbero; Mario Iannaccone; Michele De Benedictis; Baldassarre Doronzo
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

8.  Normalized lactate load is associated with development of acute kidney injury in patients who underwent cardiopulmonary bypass surgery.

Authors:  Zhongheng Zhang; Hongying Ni
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

9.  Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.

Authors:  Ryan M Brown; Li Wang; Taylor D Coston; Nathan I Krishnan; Jonathan D Casey; Jonathan P Wanderer; Jesse M Ehrenfeld; Daniel W Byrne; Joanna L Stollings; Edward D Siew; Gordon R Bernard; Wesley H Self; Todd W Rice; Matthew W Semler
Journal:  Am J Respir Crit Care Med       Date:  2019-12-15       Impact factor: 21.405

10.  Identification of Major Adverse Kidney Events Within the Electronic Health Record.

Authors:  Matthew W Semler; Todd W Rice; Andrew D Shaw; Edward D Siew; Wesley H Self; Avinash B Kumar; Daniel W Byrne; Jesse M Ehrenfeld; Jonathan P Wanderer
Journal:  J Med Syst       Date:  2016-05-27       Impact factor: 4.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.